Neurovascular Stent Retrievers Market Projected to Gain Significant Value through 2032
The market for neurovascular stent retrievers is predicted to grow at a 6.3% CAGR through 2032, with a current value of US$ 675.05 million in 2022. By 2032, the market is expected to be worth US$ 1243.57 million. The market is still seeing slow growth due to a scarcity of competent neurosurgeons and the difficult nature of neurological surgery. In the case of an acute embolic stroke, neurovascular stent retrievers are used for thrombectomy and blood flow restoration. Neurovascular stent retrievers are well-known for their ability to quickly restore blood flow and successfully remove blockages or thrombus from major intracranial arteries. Endovascular stroke is thus treated with neurovascular stent retrievers. Ischemic stroke is the leading cause of disability and death worldwide. Systemic thrombolysis with tissue plasminogen activator was utilised to treat stroke well, but the effectiveness of alternative treatments was limited in severe stroke with thromboembolic occlusion. T...